Established in Vietnam · Engineered for the world

Pharmaceutical precision.
Scientific rigour.

DO.SON Pharmaceuticals is a research laboratory dedicated to the discovery, development, and translation of new therapeutic molecules — driven by modern drug science and Vietnam's botanical heritage.

Discover the science Partner with us
15+Drug candidates in study
3Core therapeutic programmes
100%GMP-aligned manufacture
i Science-led
formulation
ii Botanical
intelligence
iii Translational
drug research
iv Made in
Vietnam

01 — Our Story

A laboratory rooted in Vietnam,
focused on the world.

DO.SON was founded with a singular vision — to advance pharmaceutical research from molecule to medicine. Inspired by Vietnam's botanical heritage and disciplined by modern drug science, we develop therapeutics that deliver measurable efficacy with uncompromising safety.

We believe progress lies not in shortcuts but in precision. Every programme is built around target validation, pharmacological evidence, and rigorous quality — never claims without data.

  • FoundedHo Chi Minh City, Vietnam
  • DisciplinePharmaceutical R&D
  • FocusDrug discovery & development
Research Laboratory Vietnam

02 — Science-led formulation

Three pillars guide every
formulation we release.

01

Pharmacological Research

Our programmes are grounded in molecular target validation, mechanism-of-action studies, and preclinical pharmacology. Safety and therapeutic value remain the foundation of every candidate we advance.

02

Advanced Drug Delivery

Stabilised APIs, biotechnology-derived intermediates, and next-generation delivery systems ensure optimal bioavailability and therapeutic index — efficacy without compromise.

03

Precision Manufacturing

Produced under strict pharmaceutical standards, each batch undergoes rigorous quality control to ensure purity, stability, and lot-to-lot consistency.

Efficacy firstEvidence-based outcomes before any release.
Responsible innovationEthical sourcing & full transparency.
Patient-centric scienceLong-term therapeutic value over hype.

03 — Our approach

Where laboratory rigour
meets botanical poetry.

I

Discovery in the field

Vietnam's biodiversity offers a rich library of bioactive compounds — lotus, mangosteen, green tea, fermented rice. We study them not as folklore but as pharmacological leads, characterised molecule by molecule.

  • Natural-product screening
  • Phytochemical analysis
  • Target identification
II

Stabilised by chemistry

Active molecules are fragile. We engineer formulation and delivery systems — encapsulation, fermentation, buffering — so each API remains potent and bioavailable from manufacture to administration.

  • Encapsulation
  • Fermentation
  • Pharmaceutical chemistry
III

Validated by evidence

Every candidate is tested against pharmacological, safety, and tolerance endpoints before progressing — efficacy is never assumed, only demonstrated.

  • In-vitro assays
  • Preclinical safety
  • Analytical QC

A glimpse

The quiet beauty
of our work.

Behind every formula sits a year of observation — cells, crystals, plants and reactions, each studied with the same curiosity.

01 · In-vitro

Cellular field

Keratinocyte proliferation under controlled stimulation.

02 · Molecular

Crystal lattice

Stabilised antioxidant geometry at the molecular scale.

03 · Botanical

Leaf macrography

Vascular structure of a Vietnamese lotus, magnified ×40.

04 · Synthesis

Catalysed pathway

Stepwise refinement — from raw extract to stabilised active.

04 — Our research process

From discovery to therapy,
in disciplined steps.

  1. 01

    Lead discovery

    Vietnamese botanicals and synthetic libraries are screened and characterised for activity, purity, and reproducibility before entering the pipeline.

  2. 02

    API stabilisation

    Each candidate molecule is encapsulated, buffered, or fermented to maximise stability, solubility, and bioavailability.

  3. 03

    Preclinical & pharmacology studies

    Candidates are evaluated on mechanism, safety, and PK/PD profiles before any clinical step is considered.

  4. 04

    Pilot & pharmaceutical-grade scale

    Validated drugs transition to GMP-aligned manufacture with full lot traceability and quality control.

"We pursue medicines that endure — therapies designed not for a single trend, but for patients who deserve safer, more effective treatment for decades."

— DO.SON Research Team

05 — Contact

Let's start a
conversation.

We collaborate with research partners, clinicians, pharmaceutical manufacturers, and academic institutions who share our standards. Tell us a little about your interest and our team will be in touch within two business days.

Get in touch

By submitting, you agree to be contacted by DO.SON Pharmaceuticals regarding your enquiry. We never share your information.